United States Diabetes Devices Market Size (2024 - 2029)

The United States Diabetes Devices Market is projected to experience significant growth over the forecast period, driven by the increasing prevalence of diabetes, which poses a higher risk of health complications and hospitalizations. This rising demand for diabetes management solutions is influencing the market's expansion. The market's growth is further supported by the need for continuous glucose monitoring, especially among diabetes patients who are at greater risk of severe symptoms and complications from infections like COVID-19.

Home Market Analysis Healthcare Research Device Drug Combination Research Diagnostics and Therapeutics Research Diabetes Care Research US Diabetes Devices Market Market Size

Market Size of United States Diabetes Devices Industry

United States Diabetes Devices Market Summary
Study Period 2019- 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 25.16 Billion
Market Size (2029) USD 34.10 Billion
CAGR (2024 - 2029) 6.27 %

Major Players

United States Diabetes Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

US Diabetes Devices Market Analysis

The United States Diabetes Devices Market size is estimated at USD 25.16 billion in 2024, and is expected to reach USD 34.10 billion by 2029, growing at a CAGR of 6.27% during the forecast period (2024-2029).

Diabetes is associated with many health complications. Comparing the population with and without diabetes, those with diabetes have a 300% increased risk of being hospitalized and, thus, incur more healthcare expenses compared to non-diabetic people. People with diabetes face a higher chance of experiencing serious complications from COVID-19. Doctors and the government are asking diabetes patients to check their glucose levels continuously. In general, people with diabetes are more likely to experience severe symptoms and complications when infected with a virus. 

According to the AACE (American Association of Clinical Endocrinologists), recent studies have shown that of those hospitalized for severe disease, 22.2-26.9% reported living with diabetes. Diabetes and high glucose levels are associated with increased complications, respiratory failure, and mortality in hospitalized patients with coronavirus.

As of the most recent update in January 2022, diabetes remains a prominent health issue in the United States, impacting a considerable number of individuals. Approximately 34.2 million people, which accounts for 10.5% of the population, are living with diabetes. This figure encompasses both diagnosed and undiagnosed cases.

The majority of diabetes cases in the United States are classified as type 2 diabetes, making up around 90-95% of all diagnosed cases. Type 2 diabetes is closely associated with lifestyle factors such as obesity, physical inactivity, and poor dietary habits.

Although less prevalent, type 1 diabetes still affects a significant number of individuals, particularly children and young adults. It is estimated that approximately 1.6 million Americans have type 1 diabetes.

Thus due to increasing diabetes population in united states is driving the market in projected time frame.

US Diabetes Devices Industry Segmentation

Patients with diabetes can monitor and control their blood glucose levels with the aid of diabetes devices. Diabetes patients' health can be dramatically improved by using diabetes devices. The United States diabetes device market is segmented into management devices and monitoring devices. The report offers the value (in USD) and volume (in units) for the above segments.

Monitoring Devices
Self-monitoring Blood Glucose
Glucometer Devices
Blood Glucose Test Strips
Lancets
Continuous Glucose Monitoring
Sensors
Durables
Management Devices
Insulin Pump
Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes
Cartridges in Reusable pens
Insulin Disposable Pens
Jet Injectors
Need A Different Region Or Segment?
Customize Now

United States Diabetes Devices Market Size Summary

The United States diabetes devices market is poised for significant growth, driven by the increasing prevalence of diabetes and the rising awareness of advanced diabetes management technologies. The market is characterized by a semi-consolidated structure with key players like Abbott, Dexcom, and Medtronic leading the charge in technological innovations. The prevalence of diabetes, particularly type 2, is exacerbated by lifestyle factors such as obesity and physical inactivity, making diabetes one of the fastest-growing chronic diseases in the country. This surge in diabetes cases has spurred demand for diabetes care devices, including continuous glucose monitoring systems and insulin delivery technologies, which are becoming more sophisticated and user-friendly. The market is also witnessing a wave of innovations from startups, enhancing the competitive landscape and driving further advancements in diabetes management solutions.

The continuous glucose monitoring segment is expected to experience robust growth, fueled by technological advancements that improve sensor accuracy and reduce costs. These devices offer real-time glucose level monitoring, providing patients with detailed insights into their blood sugar patterns. Despite the higher expenditure on these devices by type-1 diabetic patients, the adoption among type-2 diabetics is growing, aided by cost-reducing innovations like cell phone integration. The market's expansion is further supported by strategic mergers and acquisitions, such as Dexcom's acquisition of TypeZero Technologies, which aim to enhance automated insulin delivery systems. Regulatory approvals, like the FDA's clearance of Roche's Accu-Chek Solo micropump system, underscore the ongoing advancements and regulatory support for diabetes care devices, promising a dynamic and evolving market landscape over the forecast period.

Explore More

United States Diabetes Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products and Services

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Monitoring Devices

      1. 2.1.1 Self-monitoring Blood Glucose

        1. 2.1.1.1 Glucometer Devices

        2. 2.1.1.2 Blood Glucose Test Strips

        3. 2.1.1.3 Lancets

      2. 2.1.2 Continuous Glucose Monitoring

        1. 2.1.2.1 Sensors

        2. 2.1.2.2 Durables

    2. 2.2 Management Devices

      1. 2.2.1 Insulin Pump

        1. 2.2.1.1 Insulin Pump Device

        2. 2.2.1.2 Insulin Pump Reservoir

        3. 2.2.1.3 Infusion Set

      2. 2.2.2 Insulin Syringes

      3. 2.2.3 Cartridges in Reusable pens

      4. 2.2.4 Insulin Disposable Pens

      5. 2.2.5 Jet Injectors

United States Diabetes Devices Market Size FAQs

The United States Diabetes Devices Market size is expected to reach USD 25.16 billion in 2024 and grow at a CAGR of 6.27% to reach USD 34.10 billion by 2029.

In 2024, the United States Diabetes Devices Market size is expected to reach USD 25.16 billion.

US Diabetes Devices Market Report Snapshots

US Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)